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hepatocytes and secretion of proinﬂammatory cytokines
IFNg and TNFa to inhibit HBV replication noncytolytically.
Since these inhibitory cytokines are produced not only
by CTL, but also by enriched, activated populations of
hepatic NK and NKT-cells, it is now clear that NK and
NKT-cells contribute to resolution of acute hepatitis B.
HBV-speciﬁc T-cell immune responses are also modulated by
CD4 T regulatory cells. The role of HBV-speciﬁc antibodies
in resolution is less clear; however, once acute infection
is resolved the combination of HBV-speciﬁc cellular and
humoral immunity prevents reactivation of HBV replication
from residual nuclear cccDNA templates. The risk of
reactivation remains if immunological control is disrupted
by immunosuppressive drugs or cytoablative chemotherapy.
Persistent HBV infection, which occurs in the majority
of neonates and infants but only a minority of adults,
is favored by several viral and host factors. The viral
factors include the subversion of innate immunity, a high
rate of replication favoring mutational escape, absence
of hepatocyte gene induction, tolerogenic properties of
secreted HBeAg and HBsAg, HBx inhibition of proteasome
processing of antigens and HBx induction of aberrant
class II MHC and ICAM-1 to favor clonal T-cell anergy
due to absence of costimulatory signaling. Host factors
associated with persistence include decreased numbers
and defective function of plasmacytoid-dendritic cells,
decreased expression of TLR and class I MHC, decreased
production of MDL and APOBEC3 cytidine deaminases,
CTLA-4 polymophorisms, CD4 T regulatory cell activity and
CTL suppression mediated by paracrine activation of PD-1.
Overall, chronic hepatitis B is associated with a paucity
of HBV-speciﬁc CTL, activated HBV-speciﬁc CD4 T helper 1
cells and hepatic inﬂammatory inﬁltrates enriched for NK,
NKT and other antigen-nonspeciﬁc cells. Perpetuation of
antigen-nonspeciﬁc inﬂammation favors progressive ﬁbrosis.
Better understanding of the immunopathogenesis of HBV
infection has also provided insights into the mechanisms
responsible for ﬂares during chronic infection, reactivation
following immunosuppression or chemotherapy, vasculitis
and recurrent HBV infection after liver transplantation.
Ultimately, complete understanding of the immunology of
HBV infection will likely lead to new therapeutic strategies.
I-27 New cell culture and mouse models of
HBV replication
H. Tang. Department of Infectious Diseases, West China
Hospital of Sichuan University, Chengdu, Sichuan, China
Hepatitis B virus (HBV) infection is a worldwide health
problem. Understanding of the HBV life cycle especially the
replication mechanism may provide potential targets for
the development of anti-HBV treatment. Cell culture and
animal models with HBV replication are the most important
tools for studies on the mechanism of HBV replication, the
pathogenesis of HBV-related liver diseases, and the selection
of anti-HBV drugs.
Hepatotropism is a prominent feature of hepatitis B virus
(HBV) infection. Cell lines of non-hepatic origin do not
independently support HBV replication hepatic origin. In
our study, a new HBV nonhepatoma cell replication system
has been developed where pregenomic RNA synthesis
and consequently HBV replication are controlled by the
ectopic expression of liver-enriched transcription factors.
We show that the nuclear hormone receptors, hepatocyte
nuclear factor 4 (HNF4) or retinoid X receptor a (RXRa)
plus peroxisome proliferator-activated receptor a (PPARa),
support HBV replication in non-hepatic cells, indicating
these liver-enriched transcription factors represent a major
determinant governing the hepatotropism of HBV. With
this new HBV replication system, many roles of the
liver-enriched transcription factors in controlling HBV
transcription and replication have been identiﬁed.
Until recently, most in vivo studies on HBV have been
performed by using HBV transgenic mice. However, the
acquisition of transgenic mice is very time-consuming and
laborious, because expensive microinjection equipment and
complicated technology is needed. Recently, we developed
a new mouse model with HBV replication by using a
hydrodynamic procedure that provides a simple, convenient
and useful tool for molecular-biological studies on HBV, and
for the selection of anti-HBV drugs.
I-28 Association between epidermal growth factor gene
polymorphisms and the risk of hepatocellular
carcinoma in patients with hepatitis B virus chronic
infection
F.M. Lu, Y.J. Li, Q. Xie, H. Zhuang. Department of
Microbiology, Peking University Health Science Center,
Beijing, 100191, China
Aims: Epidermal growth factor (EGF) is a multifunctional
growth factor, and plays an important role in tumorigenesis,
including hepatocellular carcinoma (HCC). A single
nucleotide polymorphism (SNP) at position 61 in the 5′-
untranslated region (UTR) of the EGF gene has been
reported to modulate the transcription level of this gene
and is associated with the level of EGF protein expression in
serum or plasma. In present study the relationship between
EGF 61A/G polymorphism, EGF protein expression level,
and risk of HCC in patients with hepatitis B virus chronic
infection were assessed.
Materials and Methods: EGF gene 61A/G allele was
genotyped in ten human HCC cell lines and one immortalized
normal liver cell line. Furthermore, genomic DNA samples
from 195 HCC patients, 149 cirrhosis patients, and 186
healthy control subjects were also examined. Polymerase
chain reaction restriction fragment-length polymorphism
(PCR-RFLP) was used to determine the EGF polymorphism
genotype. EGF protein in different polymorphism genotype
from healthy control subjects was quantiﬁed by using an
enzyme-linked immmunosorbent assay (ELISA). HCC cell
lines with different polymorphic genotype were subjected
to growth assay in the presence of geﬁtinib, one EGFR
blocker.
Results: Six of the examined HCC cell lines were GG
genotype (HBxF344, Hep3B, SKHep1, SNU182, SNU387 and
SNU449), 3 were GA genotype (HepG2, PLC/PRF5 and
SMMC7721), SNU475 and the immortalized LO2 was AA
genotype. Allele frequencies of EGF SNP61*A and SNP61*G
in control group were 28.76% and 71.24%, while they
were 27.18% and 72.82%, 32.89% and 67.11% in HCC group
and cirrhosis group respectively. There was no signiﬁcant
difference in SNP61*A frequencies between hepatocellular
carcinoma group and healthy control group, as well as
cirrhosis group and healthy control group. And SNP61*A
frequencies in HCC group have no difference from cirrhosis
group, however, patients with a GA or GG genotype
had a respectively 2.3- and 1.9-fold odds of developing
hepatocellular carcinoma compared with patients with the
AA genotype, indicating that AA genotype may have lower
HCC risk. Concordantly, a signiﬁcant higher EGF protein
level in GG and GA genotype compared to AA genotype was
found. In addition, EGF gene polymorphisms at position 19,
101, 341 were also examined from 78 healthy subjects, 53
HCC patients, all were homozygote. In order to conﬁrm
whether EGFR blocker can affect the proliferation of cell
with different genotypes, six cell lines were treated by
geﬁtinib. We observed that cell proliferation of HBxF344,
SKHep1 with the GG genotype was reduced by geﬁtinib
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compared to that of HepG2 or SNU475 with the GA or AA
genotype.
Conclusions: Our ﬁndings suggested that the EGF 61AA
genotype may lower HCC risk compared with GG and GA
genotypes, and have lower level of EGF protein. In addition,
block EGF signaling transduction via geﬁtinib can slowdown
the proliferations of some HCC cell lines.
I-29 The natural history of infections caused by
varicella-zoster virus (VZV): primary infection,
transmission, latency, and reactivation.
M.D. Gershon*. Department of Pathology & Cell Biology,
Columbia University College of Physicians and Surgeons,
New York, USA
Studies of live attenuated varicella vaccine (Oka strain)
have led to increased understanding of the behavior of this
virus in human populations. For example, it has become
clear that VZV spreads predominately from the skin lesions
of patients with varicella (chickenpox) or zoster (shingles),
which contain high concentrations of cell-free virions that
are highly transmissible to others by the airborne route. At
least 3 cellular receptors for VZV have been identiﬁed.
This presentation will focus on the importance of the
mannose 6-phosphate receptor (MPR) and its role in viral
entry and egress from cells. Because MPRs are lost during
the natural maturation of the superﬁcial epidermis, VZV-
infected maturing keratinocytes release infectious viral
particles into the epidermal vesicles that form during
varicella or zoster. In human infection, cellular immunity
is required for host defense against VZV because non-
epidermal cells express MPRs and thus do not release
infectious virions. VZV thus spreads from one cell to another
without entering the extracellular space. The exclusive
cell-to-cell spread of VZV in the body contributes to the
relatively long varicella incubation period, decreases the
viral load during disease (because much of the intracellular
virus is degraded in endosomes), and prevents the host
from being overwhelmed by VZV. In evolutionary terms, it
is an advantage for the virus not to overwhelm its host
and to establish a latent infection so that it can persist
after a varicella epidemic has exhausted the population of
susceptible hosts, and reactivate to spread again, after a
population of susceptible hosts is regenerated.
In an in vitro neuronal model of VZV infection, only cell-free
VZV establishes latent infection. Because the epidermis is
the only site in which infectious free virions emerge, this
observation suggests that skin infection is necessary for the
establishment of VZV latency. Infection of intraepidermal
sensory nerve terminals enables VZV to establish latency
in dorsal root and cranial nerve ganglia. During latency, a
limited number of VZV genes are transcribed. The same
genes are transcribed during latency in infected human
ganglia and in cultured intestinal neurons isolated from
either guinea pig or mouse. This neuronal model of VZV
infection is useful because lytic or latent infections can
be studied and VZV can be reactivated from latency. Both
wild-type VZV and the vaccine (Oka) strain can establish
latency and reactivate in neurons in vitro.
Basic studies on VZV have helped to promote understanding
of how varicella vaccine behaves in human hosts. This
knowledge, in turn, has contributed to recommendations
for vaccine use. For example, the risk of manifesting zoster
is low in vaccinees who lack a history of skin lesions from
either vaccine or wild type VZV. In addition, skin lesions with
infectious VZV are required for host-to-host transmission;
therefore, decreasing the number of skin lesions due to VZV
decreases VZV transmission. In order to maximize protection
of vaccinees from chickenpox and minimize skin lesions, two
doses of vaccine are now recommended for all children in
the United States.
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I-30 Antibiotics application in China
Y.H. Xiao*. Institute of Clinical Pharmacology, Peking
University, Beijing, 100083, China
Antimicrobial agents is the most frequent prescribed
drug in China, near 40% of the drug consumption is
antimicrobial agents, 60 70% of hospitalized patients
receive antimicrobial agent therapy and 20 30% outpatient
prescriptions contain those agents. The top three
antimicrobials by the drug classiﬁcation are ﬂuoroquinolone,
cephalosporin and macrolide. The irrational antibiotic
application is a severe public health problem in China.
In community and hospital setting, antimicrobials
are used for the treatment of bacterial infection,
common cold and other un-infectives. The catalog of
antimicrobials irrational use reasons includes prescription
without indication, favoring intravenous administration,
unnecessary combination, longer duration, higher dosage
and others.
Except healthcare consumption, half of the antibiotic
output is used in animal breeding as growth promoter,
which is added in the animal feeding.
The reasons of irrational use are: healthcare system
ﬁnancial compensation defect, patient claim and pressure,
unmet physician education, STG unavailable and industrial
promotion.
The results of irrational use of antimicrobials are:
1. Severe bacterial resistance: 70% E. coli being
resistant to ﬂuoroquinolone, over 80% macrolide-
resistant Streptococcus and Staphylococcus being
detected, ESBLs(+) Enterobacteriaceae being 10 20%,
penicillin non-sensitive S. pneumoniae increasing
steadily, methicillin-resistant Staphylococcus being 60%
national-widely, etc.
2. Antibiotic-related ADR and drug sufferings: 50% ADR
report collected in national ADR center was antibiotic-
related, some national wide drug sufferings was reported
occasionally.
3. Wasting medicinal resource.
The measures ﬁghting against the antibiotic irrational use
should be:
1. Healthcare system reform, which is being on the way.
2. STG generating and enforcing; some hospitals or medical
associations are preparing their own STG.
3. Professional employees and patients education.
4. Legalization industrial promotion.
5. Restriction of animal use for growth promoter.
I-31 Prenyltransferases as targets for antibiotic drug
discovery
A.H.J. Wang*. Institute of Biological Chemistry, Academia
Sinica, Taipei 11529, Taiwan
Prenyltransferases are involved in many biological
pathways; thus they are useful for developing new drugs
for various diseases. We have studied by structural analysis
the product chain length determinants of several trans-type
prenyltransferases, including geranylgeranyl pyrophosphate
synthase (GGPPS) and so on. The speciﬁcities were
determined by the size and depth of the activity site
cavity. Large amino acids form the ﬂoor to block product
further elongation. In addition, we solved the structures
